跳到正文

Hohl Benjamin 内部人交易:近期 SEC Form 4 交易

过去 18 个月,Hohl Benjamin(CIK 1882764)在 1 家公司共报告 35 笔 SEC Form 4 内部人交易(最近一笔 2026-10-21)。

日期公司身份类型股数市值
2026-10-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER买入6,018$89,367
2026-10-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出6,018$231,546
2026-09-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出3,535$176,856
2026-09-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER买入3,982$59,133
2026-09-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出2,194$111,280
2026-09-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出289$14,881
2026-08-19Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出4,630$270,160
2026-08-19Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出1,388$82,378
2026-07-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER买入1,072$2,659
2026-07-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出324$16,190
2026-07-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出369$18,996
2026-07-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出2,564$134,148
2026-07-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出123$6,626
2026-07-21Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出2,638$140,816
2026-06-22Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER买入6,018$14,925
2026-06-22Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出1,379$59,007
2026-06-22Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出3,401$149,168
2026-06-22Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出1,238$55,400
2026-03-10Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出10,000$295,800
2026-02-17Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER买入25,000$0
2025-12-23Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER买入13,000$32,240
2025-10-01Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER买入3,250$8,060
2025-10-01Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出3,250$66,300
2025-08-29Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER卖出3,250$67,048
2025-08-29Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICER买入3,250$8,060

来源:SEC Form 4 申报文件 · 截至 2026-10-21